Editas Medicine
EDIT
EDIT
237 hedge funds and large institutions have $517M invested in Editas Medicine in 2023 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 75 increasing their positions, 48 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% more funds holding
Funds holding: 234 → 237 (+3)
1.04% more ownership
Funds ownership: 76% → 77.04% (+1%)
Holders
237
Holding in Top 10
–
Calls
$8.36M
Puts
$4.83M
Top Buyers
| 1 | +$28.4M | |
| 2 | +$24.7M | |
| 3 | +$23.4M | |
| 4 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
+$8.02M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.92M |
Top Sellers
| 1 | -$12.5M | |
| 2 | -$10.6M | |
| 3 | -$4.93M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$4.23M |
| 5 |
Citigroup
New York
|
-$3.67M |